Evidence map›Paper›PMID 16895275›Full record

ArticleJournal of the National Medical Association2006

Race and medication adherence in Medicaid enrollees with type-2 diabetes.

Rahul A Shenolikar, Rajesh Balkrishnan, Fabian T Camacho, J Timothy Whitmire, Roger T Anderson

Registry-linked trialAbstract read
In one paragraph

Article in Journal of the National Medical Association, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02621476 (Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities), which is not on this map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02621476 nacompletednot on this mapstarted 2017, after this paper: background citation

Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities

TypeinterventionalSponsorKaiser PermanenteRan2017 to 2022Enrolled63,012ConditionsDiabetes MellitusArmsStandardized intervention, Usual care
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Emergency Department Use in Black Individuals With Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rahul A ShenolikarDepartment of Pharmacy Practice and Administration, The Ohio State University College of Pharmacy, Columbus, OH, USA.
Rajesh Balkrishnan
Fabian T Camacho
J Timothy Whitmire
Roger T Anderson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe association of medication adherence with race has been inadequately studied previously in type-2 diabetes patients. The study objective was to determine the association between race and medication adherence among type-2 diabetes patients.

methodsThis was a retrospective cohort study, which compared medication adherence among different races of Medicaid insured patients with type-2 diabetes newly starting oral antidiabetic medication. A total of 1,527 African-American patients newly starting antidiabetic medication between July 2001 and June 2002 were compared with 1,128 white patients and 514 patients of other race. Medication adherence was measured as medication possession ratio using prescription refill patterns. Multivariate regression analyses were used to determine the difference in adherence rates adjusting for other covariates.

resultsMedication adherence rate was significantly higher for whites [0.59 (0.31)] as compared to African Americans [0.54 (0.31), (p<0.05)]. In multivariate analyses, the adherence rate of African-American patients was found to be significantly lower by 12% as compared to whites after adjusting for other covariates. Metformin users were associated with a 62% decrease in adherence rate as compared with the sulfonylureas group (p<0.05).

conclusionThe antidiabetic medication adherence was associated with race. Future research should investigate patient-related factors affecting medication adherence in type-2 diabetes patients.

Indexed as

AdolescentAdultAgedBlack or African AmericanCohort StudiesDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsMaleMedicaidMetforminMiddle AgedPatient ComplianceRetrospective StudiesSulfonylurea CompoundsHypoglycemic AgentsMetforminSulfonylurea Compounds

Identifiers

PMID16895275
PMCPMC2569450

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.